The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Tumor‐associated macrophages exhibit pro‐ and anti‐inflammatory properties by which they impact on pancreatic tumorigenesis
Open accessAbstract
Pancreatic ductal adenocarcinoma (PDAC) still ranking 4th in the order of fatal tumor diseases is characterized by a profound tumor stroma with high numbers of tumor‐associated macrophages (TAMs). Driven by environmental factors, monocytes differentiate into M1‐ or M2‐macrophages, the latter commonly regarded as being protumorigenic. Because a detailed analysis of TAMs in human PDAC development is still lacking, freshly isolated PDAC‐derived TAMs were analyzed for their phenotype and impact on epithelial‐mesenchymal‐transition (EMT) of benign (H6c7) and malignant (Colo357) pancreatic ductal epithelial cells. TAMs exhibited characteristics of M1‐macrophages (expression of HLA‐DR, IL‐1β, or TNF‐α) and M2‐macrophages (expression of CD163 and IL‐10). In the presence of TAMs, H6c7, and Colo357 cells showed an elongated cell shape along with an increased expression of mesenchymal markers such as vimentin and reduced expression of epithelial E‐cadherin. Similar to TAMs, in vitro generated M1‐ and M2‐macrophages both mediated EMT in H6c7 and Colo357 cells. M1‐macrophages acquired M2‐characteristics during coculture that could be prevented by GM‐CSF treatment. However, M1‐macrophages still potently induced EMT in H6c7 and Colo357 cells although lacking M2‐characteristics. Overall, these data demonstrate that TAMs exhibit anti‐ as well as proinflammatory properties that equally contribute to EMT induction in PDAC initiation and development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Macrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., & Udalova, I. A. (2011) · Nature Immunology · doi:10.1038/ni.1990 · Cited by 1,306
Zhang, Q.-W., Liu, L., Gong, C.-Y., Shi, H.-S., Zeng, Y.-H., Wang, X.-Z., Zhao, Y.-W., & Wei, Y.-Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050946 · Cited by 1,039
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Germano, G., Frapolli, R., Belgiovine, C., Anselmo, A., Pesce, S., Liguori, M., Erba, E., Uboldi, S., Zucchetti, M., Pasqualini, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.008 · Cited by 864
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Ino, Y., Yamazaki-Itoh, R., Shimada, K., Iwasaki, M., Kosuge, T., Kanai, Y., & Hiraoka, N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.32 · Cited by 849
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792
Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer
Kurahara, H., Shinchi, H., Mataki, Y., Maemura, K., Noma, H., Kubo, F., Sakoda, M., Ueno, S., Natsugoe, S., & Takao, S. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2009.05.026 · Cited by 552
Verreck, F. A. W., de Boer, T., Langenberg, D. M. L., van der Zanden, L., & Ottenhoff, T. H. M. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0105015 · Cited by 373
Inflammation and the development of pancreatic cancer
Farrow, B., & Evers, B. M. (2002) · Surgical Oncology · doi:10.1016/s0960-7404(02)00015-4 · Cited by 338
Immortal Human Pancreatic Duct Epithelial Cell Lines with Near Normal Genotype and Phenotype
Ouyang, H., Mou, L.-J., Luk, C., Liu, N., Karaskova, J., Squire, J., & Tsao, M.-S. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64800-6 · Cited by 313
Hattermann, K., Held-Feindt, J., Lucius, R., Müerköster, S. S., Penfold, M. E. T., Schall, T. J., & Mentlein, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3642 · Cited by 295
Self-citationPancreatic Cancer: Basic and Clinical Aspects
Schneider, G., Siveke, J. T., Eckel, F., & Schmid, R. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.001 · Cited by 289
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors
Bonde, A.-K., Tischler, V., Kumar, S., Soltermann, A., & Schwendener, R. A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-35 · Cited by 283
Müerköster, S., Wegehenkel, K., Arlt, A., Witt, M., Sipos, B., Kruse, M.-L., Sebens, T., Klöppel, G., Kalthoff, H., Fölsch, U. R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1860 · Cited by 254
Pancreatic cancer microenvironment
Kleeff, J., Beckhove, P., Esposito, I., Herzig, S., Huber, P. E., Löhr, J. M., & Friess, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22871 · Cited by 225
Cancer‐promoting tumor‐associated macrophages: New vistas and open questions
Mantovani, A., Germano, G., Marchesi, F., Locatelli, M., & Biswas, S. K. (2011) · European Journal of Immunology · doi:10.1002/eji.201141894 · Cited by 207
Identification of a novel dendritic cell-like subset of CD64(+) / CD16(+) blood monocytes.
Quin, S. J., Seixas, E. M., Cross, C. A., Berg, M., Lindo, V., Stockinger, B., & Langhorne, J. (2001) · PubMed · doi:10.1002/1521-4141(200101)31:1<48::aid-immu48>3.0.co;2-5 · Cited by 163
CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs)
Held‐Feindt, J., Hattermann, K., Müerköster, S. S., Wedderkopp, H., Knerlich‐Lukoschus, F., Ungefroren, H., Mehdorn, H. M., & Mentlein, R. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.018 · Cited by 154
Self-citationLiu, G., Furukawa, T., Kobari, M., & Tsao, M. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65567-8 · Cited by 151
Identification of a novel dendritic cell-like subset of CD64+ / CD16+ blood monocytes
Grage‐Griebenow, E., Zawatzky, R., Kahlert, H., Brade, L., Flad, H., & Ernst, M. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200101)31:1<48::aid-immu48>3.0.co;2-5 · Cited by 142
Self-citationKawata, M., Koinuma, D., Ogami, T., Umezawa, K., Iwata, C., Watabe, T., & Miyazono, K. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvr136 · Cited by 136
Müerköster, S. S., Werbing, V., Sipos, B., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1210076 · Cited by 122
Kurahara, H., Takao, S., Maemura, K., Mataki, Y., Kuwahata, T., Maeda, K., Sakoda, M., Iino, S., Ishigami, S., Ueno, S., et al. (2012) · Pancreas · doi:10.1097/mpa.0b013e318254f2d1 · Cited by 102
Geismann, C., Morscheck, M., Koch, D., Bergmann, F., Ungefroren, H., Arlt, A., Tsao, M., Bachem, M. G., Altevogt, P., Sipos, B., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3493 · Cited by 96
Self-citationLin, C., Lin, C., Chen, K.-H., Wu, J.-C., Huang, S.-H., & Wang, S. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.049 · Cited by 91
Müerköster, S. S., Werbing, V., Koch, D., Sipos, B., Ammerpohl, O., Kalthoff, H., Tsao, M., Fölsch, U. R., & Schäfer, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23703 · Cited by 73
Self-citationSchäfer, H., Struck, B., Feldmann, E.-M., Bergmann, F., Grage‐Griebenow, E., Geismann, C., Ehlers, S., Altevogt, P., & Sebens, S. (2012) · Oncogene · doi:10.1038/onc.2012.44 · Cited by 51
Self-citation
Cited by
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398
New insights into the multidimensional concept of macrophage ontogeny, activation and function
Ginhoux, F., Schultze, J. L., Murray, P. J., Ochando, J., & Biswas, S. K. (2016) · Nature Immunology · doi:10.1038/ni.3324 · Cited by 833
Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages
Chávez-Galán, L., Olleros, M. L., Vesin, D., & Garcia, I. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00263 · Cited by 653
The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
Fu, L.-Q., Du, W.-L., Cai, M.-H., Yao, J.-Y., Zhao, Y.-Y., & Mou, X.-Z. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104119 · Cited by 415
Regulation of Placental Extravillous Trophoblasts by the Maternal Uterine Environment
Pollheimer, J., Vondra, S., Baltayeva, J., Beristain, A. G., & Knöfler, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02597 · Cited by 412
Metadata
- Authors
- Helm, O., Held‐Feindt, J., Grage‐Griebenow, E., Reiling, N., Ungefroren, H., Vogel, I., Krüger, U., Becker, T., Ebsen, M., Röcken, C., Kabelitz, D., Schäfer, H., & Sebens, S.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2014-02-05
- Volume
- 135
- Issue
- 4
- Pages
- 843-861
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1551186235
- Cited by
- 260
- References
- 34
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.